◆英語タイトル:GATT Technologies BV - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12203
◆発行会社(調査会社):
GlobalData
◆発行日:2018年12月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
GATT Technologies BV (GATT Technologies) is a medical technology company which develops synthetic surgical hemostat and sealant products that control severe bleeding. Its product pipeline includes GATT-Patch for controlling excessive bleeding; GATT-Tape for blocking intestinal anastomotic leakage; GATT-Powder, a one syringe solution for preventing uncontrolled bleeding and anti-coagulated blood; and GATT-Spray, a sturdy adhesive elastic sealant in general surgery. The company developed its GATT platform technology using a synthetic polymer that has hemostatic and sealant properties, through the reaction of an electrophilic activated polyoxazoline (NHS-POx) with a nucleophilic cross-linking agent. GATT Technologies is headquartered in Nijmegen, the Netherlands.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company GATT Technologies BV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
GATT Technologies BV Company Overview 4
GATT Technologies BV Company Snapshot 4
GATT Technologies BV Pipeline Products and Ongoing Clinical Trials Overview 4
GATT Technologies BV – Pipeline Analysis Overview 6
GATT Technologies BV – Key Facts 6
GATT Technologies BV – Major Products and Services 7
GATT Technologies BV Pipeline Products by Development Stage 8
GATT Technologies BV Pipeline Products Overview 9
GATT-Patch 9
GATT-Patch Product Overview 9
GATT-Powder 10
GATT-Powder Product Overview 10
GATT-Spray 11
GATT-Spray Product Overview 11
GATT-Tape 12
GATT-Tape Product Overview 12
GATT Technologies BV – Key Competitors 13
GATT Technologies BV – Key Employees 14
GATT Technologies BV – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
GATT Technologies BV, Recent Developments 16
Jul 04, 2017: OP-East subsidy for pre-clinical phase GATT Patch 16
Appendix 17
Methodology 17
About GlobalData 20
Contact Us 20
Disclaimer 20
List of Tables
GATT Technologies BV Pipeline Products and Ongoing Clinical Trials Overview 4
GATT Technologies BV Pipeline Products by Equipment Type 5
GATT Technologies BV Pipeline Products by Indication 5
GATT Technologies BV, Key Facts 6
GATT Technologies BV, Major Products and Services 7
GATT Technologies BV Number of Pipeline Products by Development Stage 8
GATT Technologies BV Pipeline Products Summary by Development Stage 8
GATT-Patch - Product Status 9
GATT-Patch - Product Description 9
GATT-Powder - Product Status 10
GATT-Powder - Product Description 10
GATT-Spray - Product Status 11
GATT-Spray - Product Description 11
GATT-Tape - Product Status 12
GATT-Tape - Product Description 12
GATT Technologies BV, Key Employees 14
Glossary 19
List of Figures
GATT Technologies BV Pipeline Products by Equipment Type 5
GATT Technologies BV Pipeline Products by Development Stage 8